tiprankstipranks
Nirvana Life Sciences Inc (TSE:NIRV)
:NIRV
Canadian Market

Nirvana Life Sciences Inc (NIRV) Income Statement

Compare
6 Followers

Nirvana Life Sciences Inc Income Statement

Last quarter (Q3 2023), Nirvana Life Sciences Inc's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, Nirvana Life Sciences Inc's net income was C$5.37K. See Nirvana Life Sciences Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 23Jun 22Dec 20Dec 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Operating Expenses
-C$ 1.18MC$ 314.24KC$ 74.83K
Depreciation and Amortization
C$ 91.64KC$ 91.64K-C$ 171.86K
EBITDA
-C$ 3.40MC$ -314.24KC$ -74.53K
Operating Income
-C$ -859.12KC$ -314.24KC$ -74.53K
Other Income/Expenses
-C$ -4.49M-C$ 91.09K
Pretax Income
-C$ -5.66MC$ -314.24KC$ 13.31K
Net Income
-C$ -5.65MC$ -314.24KC$ 13.31K
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.04C$ -0.15C$ -0.01C$ 0.00
Diluted EPS
C$ -0.04C$ -0.15C$ -0.01C$ 0.00
Weighted Average Shares Outstanding
33.94K 36.52M 33.02M 33.02M
Weighted Average Shares Outstanding (Diluted)
33.94K 36.52M 33.02M 33.02M
Currency in CAD

Nirvana Life Sciences Inc Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis